Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MONTERO

Showing results (531-540 of 552) with videos related to

Pageof 56
Sort By:
Phytotherapy Research : PTR|June 26, 2024
Anti-inflammatory and anti-hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis-associated visceral painMaria Loreta Libero, Elena Lucarini, Lucia Recinella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast CancerAvia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.
Breast Cancer Research : BCR|May 24, 2024
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.
Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.
Molecular Therapy. Oncology|January 6, 2025
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic targetAntonio J Montero-Hidalgo, Enrique Gómez-Gómez, Manuel Galán-Cañete, et al.
Open Forum Infectious Diseases|July 7, 2022
Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019Jeremy A W Gold, Andrew Revis, Stepy Thomas, et al.
Journal of Investigational Allergology & Clinical Immunology|May 23, 2015
Consensus document on allergic conjunctivitis (DECA)M C Sánchez-Hernández, J Montero, C Rondon, et al.
Cell Death & Disease|May 20, 2024
CDK9 inhibition as an effective therapy for small cell lung cancerL Valdez Capuccino, T Kleitke, B Szokol, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic toolVicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.
Pageof 56

Showing results (531-540 of 552) with videos related to

Sort By:
Pageof 56
Phytotherapy Research : PTR|June 26, 2024
Anti-inflammatory and anti-hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis-associated visceral painMaria Loreta Libero, Elena Lucarini, Lucia Recinella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast CancerAvia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.
Breast Cancer Research : BCR|May 24, 2024
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.
Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.
Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.
Molecular Therapy. Oncology|January 6, 2025
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic targetAntonio J Montero-Hidalgo, Enrique Gómez-Gómez, Manuel Galán-Cañete, et al.
Open Forum Infectious Diseases|July 7, 2022
Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019Jeremy A W Gold, Andrew Revis, Stepy Thomas, et al.
Journal of Investigational Allergology & Clinical Immunology|May 23, 2015
Consensus document on allergic conjunctivitis (DECA)M C Sánchez-Hernández, J Montero, C Rondon, et al.
Cell Death & Disease|May 20, 2024
CDK9 inhibition as an effective therapy for small cell lung cancerL Valdez Capuccino, T Kleitke, B Szokol, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic toolVicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.
Pageof 56